gastritis - Nursing Case Study
Pathophysiology
• Primary mechanism: Gastritis is primarily caused by the breakdown of the protective mucosal barrier in the stomach, allowing stomach acids to damage the underlying tissue. This can occur due to factors like Helicobacter pylori infection, which disrupts the mucosal layer and triggers inflammation.
• Secondary mechanism: Nonsteroidal anti-inflammatory drugs (NSAIDs) can further contribute to mucosal damage by inhibiting the production of protective prostaglandins, exacerbating inflammation and increasing the risk of ulcers.
• Key complication: If untreated, gastritis can lead to the development of peptic ulcers, which are open sores on the stomach lining that can cause pain, bleeding, and, in severe cases, perforation of the stomach wall.
Patient Profile
Demographics:
32-year-old female, office worker
History:
• Key past medical history: Occasional heartburn, no previous hospitalizations
• Current medications: Over-the-counter antacids as needed
• Allergies: None
Current Presentation:
• Chief complaint: Mild stomach discomfort
• Key symptoms: Intermittent upper abdominal pain, nausea, bloating
• Vital signs: Blood pressure 118/76 mmHg, heart rate 72 bpm, respiratory rate 16 breaths per minute, temperature 98.4°F
Section 1
Initial Assessment Findings:
Upon further evaluation, the nurse conducts a comprehensive assessment to better understand the patient's condition and to guide the plan of care. The patient reports that her stomach discomfort worsens after meals, particularly when consuming spicy or acidic foods. She describes the pain as a dull, burning sensation in the upper abdomen that occasionally radiates to her back. The nurse notes that the patient appears slightly pale, but there are no signs of acute distress. An abdominal examination reveals mild tenderness in the epigastric region upon palpation, but no guarding or rebound tenderness is present. Bowel sounds are normal in all quadrants.
The nurse also assesses the patient's lifestyle and dietary habits, which could be contributing factors to her gastritis. The patient admits to drinking two to three cups of coffee daily and occasionally consuming alcohol on weekends. She also mentions a tendency to skip meals due to her busy work schedule, often leading to large, irregular meals later in the day. This information prompts the nurse to educate the patient on lifestyle modifications, such as reducing caffeine and alcohol intake and adopting a regular meal schedule to help manage her symptoms.
Based on the initial findings, the nurse collaborates with the physician to recommend a short-term trial of a proton pump inhibitor (PPI) to reduce stomach acid production and promote mucosal healing. The nurse plans to follow up with the patient to assess her response to the medication and to evaluate the need for further diagnostic testing, such as an H. pylori breath test or an endoscopy, if symptoms persist.
Section 2
Response to Interventions
Two weeks after initiating treatment with the proton pump inhibitor (PPI), the patient returns for a follow-up appointment. She reports a noticeable improvement in her symptoms, stating that the burning sensation has significantly decreased. She no longer experiences discomfort with every meal, particularly after avoiding spicy and acidic foods as advised. The patient has also made efforts to reduce her coffee intake to one cup per day and has limited alcohol consumption to special occasions. She has been more consistent with her meal schedule, eating smaller, more frequent meals throughout the day, which seems to have further alleviated her symptoms.
During the follow-up visit, the nurse conducts a physical examination and notes the patient's color has improved, and she no longer appears pale. The abdominal examination shows decreased tenderness in the epigastric region, and there is still no guarding or rebound tenderness. The patient's vital signs remain stable, with a blood pressure of 118/76 mmHg, heart rate of 72 beats per minute, respiratory rate of 16 breaths per minute, and a temperature of 98.6°F. The patient has not experienced any adverse effects from the PPI and is tolerating the medication well.
Given the positive response to the treatment and lifestyle modifications, the nurse and physician decide to continue the PPI for a total of six weeks to ensure complete healing of the gastric mucosa. They discuss the importance of maintaining the dietary and lifestyle changes long-term to prevent recurrence. The nurse also emphasizes the need for the patient to monitor her symptoms and advises scheduling another follow-up visit if any new symptoms arise. If the patient continues to do well, a gradual tapering off of the PPI may be considered at the next appointment, along with an assessment to determine if further testing is necessary.
Section 3
Two months following the initial diagnosis and treatment initiation, the patient returns for a routine follow-up visit. She reports that she has been feeling well overall, but has noticed occasional mild discomfort in her stomach, especially after consuming meals that are heavier or slightly spicy. Despite these minor symptoms, she continues to adhere to her dietary modifications, limiting spicy and acidic foods, and maintaining her reduced coffee and alcohol intake.
The nurse conducts a thorough assessment and observes the patient's overall well-being. Her vital signs remain within normal limits: blood pressure is 116/78 mmHg, heart rate is 70 beats per minute, respiratory rate is 16 breaths per minute, and her temperature is 98.4°F. Upon palpation of the abdomen, there is no significant tenderness, and the patient does not exhibit guarding or rebound tenderness, indicating that the gastric mucosa is likely healing well. The patient has not experienced any nausea, vomiting, or significant changes in weight, suggesting that her gastritis is being managed effectively.
Laboratory tests are reviewed, including a complete blood count (CBC) and liver function tests. The CBC reveals hemoglobin levels at 13.5 g/dL, within the normal range, reflecting no signs of anemia. Liver function tests are also normal, indicating no hepatic complications from the medication or lifestyle changes. The healthcare team is encouraged by these results and decides to begin a gradual tapering off of the PPI over the next few weeks. They reinforce the importance of maintaining lifestyle and dietary habits to prevent recurrence and advise the patient to return if symptoms escalate. This approach will help to ensure sustained recovery while minimizing the risk of dependency on medication.
Section 4
Response to Interventions:
As the patient begins the gradual tapering off of her proton pump inhibitor (PPI), the healthcare team closely monitors her response. Over the following weeks, she continues to adhere to her prescribed dietary modifications and lifestyle changes. During this period, she maintains a symptom diary to track any changes in her gastric discomfort. The nurse reviews this diary during a follow-up appointment and notes that the patient reports only occasional mild heartburn, primarily when she inadvertently consumes foods that are slightly more acidic or spicy than recommended. However, these episodes are infrequent and manageable with simple antacids, suggesting that the tapering process is proceeding smoothly.
The nurse conducts another thorough assessment at this appointment. The patient's vital signs remain stable: blood pressure is 114/76 mmHg, heart rate is 68 beats per minute, respiratory rate is 15 breaths per minute, and her temperature is 98.6°F. Abdominal examination continues to show no tenderness or signs of distress. The patient expresses satisfaction with her overall health and is pleased to be reducing her medication intake. Her commitment to lifestyle adjustments is evident, as she actively engages in discussions about expanding her dietary options while still avoiding known triggers.
The healthcare team is encouraged by the positive response to the tapering intervention and discusses with the patient the importance of vigilance for any resurgence of symptoms. They provide her with a comprehensive plan for managing minor symptoms should they arise and reinforce the importance of regular follow-up visits to monitor her condition. This collaborative approach helps empower the patient, integrating her active participation in her care plan, and sets the stage for ongoing recovery and potential long-term management of her gastritis.
Section 5
New Diagnostic Results:
At the next scheduled follow-up appointment, the healthcare team reviews the results of recent laboratory tests and a repeat endoscopy, which were ordered to monitor the patient's progress and ensure no underlying issues were overlooked. The lab results indicate normal hemoglobin levels, ruling out anemia, and normal liver and renal function tests, confirming the absence of any complications related to medication or diet. The patient's Helicobacter pylori test returns negative, reinforcing the diagnosis of non-erosive gastritis.
The endoscopy shows mild improvement in the gastric mucosa, with no new lesions or significant inflammation. The gastroenterologist notes minimal erythema, consistent with the patient's reported symptom improvement. These findings support the effectiveness of the current management plan, including the gradual reduction of the proton pump inhibitor and adherence to lifestyle modifications. The patient is advised to continue with the dietary recommendations and to keep her symptom diary updated, ensuring any changes are promptly addressed.
Encouraged by the positive diagnostic results, the healthcare team highlights the importance of maintaining open communication and ongoing monitoring. They emphasize the role of regular follow-ups in preventing potential complications and ensuring the patient's continued well-being. With a clearer picture of her condition, the patient feels reassured and motivated to stay committed to her care plan, understanding that her active involvement is crucial for long-term management of her gastritis. This comprehensive approach sets the stage for a sustained recovery and a gradual return to a more flexible lifestyle while minimizing the risk of symptom recurrence.